LFMD
Get informed when a big investor buys or sells
+ Follow| Market cap | $166.85 Million |
|---|---|
| Enterprise Value | $158.52 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 2.06 |
| Outstanding Shares | 47,788,194 |
| P/E Ratio | -6.79 |
|---|---|
| PEG | -2.81 |
| Price to Sales | 1.15 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.05 |
| Enterprise Value to EBIT | -6.26 |
| Enterprise Value to Net Income | -118 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 2.11 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 67.65% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 14.99%▼ 23.14% |
|---|---|
| Total Invested | $29.32M▼ 54.45% |
| Investors Holding | 40▼ 67.00% |
No data
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordab...